Results 41 to 50 of about 10,206 (212)

Bronchodilator reversibility testing in morbidly obese non-smokers: fluticasone/salmeterol efficacy versus salbutamol bronchodilator

BMC Pulmonary Medicine, 2023
A positive response in reversibility testing is widely used to diagnose patients with airway limitations. However, despite its simple procedure, it doesn’t accurately reflect the exact airway irreversibility.
Mona Ibrahim Ahmed, Randa Ibrahim Ahmed, Hasnaa Osama, Amira Karam Khalifa, Abdullah Ali Alshehri, Gaber El-Saber Batiha, Walaa A Negm, Marwa Kamal   +7 more
doaj   +1 more source

What Is Known About Asthma Care and Management for Children and Young People Under 18 Years of age in New Zealand. A Scoping Review

The Clinical Respiratory Journal, Volume 19, Issue 12, December 2025.
Children in Aotearoa New Zealand experience variable asthma care. This review reveals critical gaps in education, treatment adherence, and culturally safe services, disproportionately affecting Māori and Pacific children. Strengthening family/whānau‐centred and culturally responsive care is vital for improving outcomes.
J. Blamires, M. Foster, B. Kanengoni‐Nyatara   +2 more
wiley   +1 more source

INFLUENCE OF BRONCHOLYTIC THERAPY ON VENTRICULAR RHYTHM DISORDERS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Рациональная фармакотерапия в кардиологии, 2016
Aim. To evaluate effects of broncholytic therapy on ventricular rhythm disorders and high resolution electrocardiogram indices in patients with chronic obstructive pulmonary disease (COPD).Material and methods.
Kh. Kh. Shugushev, M. V. Gurizheva, V. M. Vasilenko   +2 more
doaj   +3 more sources

Efficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: A study level and a patient level network meta-analysis

BMC Pulmonary Medicine, 2012
Background The objective of this study was to evaluate the comparative efficacy of indacaterol 75 μg once daily (OD), tiotropium 18 μg OD, salmeterol 50 μg twice daily (BID), formoterol 12 μg BID, and placebo for the treatment of chronic obstructive ...
Cope Shannon, Zhang Jie, Williams James, Jansen Jeroen P   +3 more
doaj   +1 more source

Prognostic utility of pre‐biologic treatment correlates of childhood severe asthma exacerbation risk: Real world evidence

Pediatric Allergy and Immunology, Volume 36, Issue 12, December 2025.
Abstract Background Biologics have been shown to substantially reduce the risk of severe asthma exacerbations (SAEs) among children with moderate or severe asthma; however, not all eligible patients who initiate biologic treatment experience a reduced risk of SAEs.
Arthur H. Owora, Bowen Jiang, Yash Shah, Benjamin Gaston, Erick Forno   +4 more
wiley   +1 more source

Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: A one year evaluation of safety and tolerance

Therapeutic Advances in Respiratory Disease, 2008
Introduction: Concerns have been raised regarding the safety of extended use of long-acting β 2-agonists (LABAs). The safety of arformoterol (50 µg QD), and salmeterol (42 µg BID), was assessed over 12 months in subjects with COPD.
J.F. Donohue, N.A. Hanania, K.A. Sciarappa, E. Goodwin, D.R. Grogan, R.A. Baumgartner, J.P. Hanrahan   +6 more
doaj   +1 more source

Myo‐Inositol Deficiency, Structural Brain Changes, and Cerebral Perfusion Alterations in Classic Galactosemia: Preliminary Insights From a Multiparametric MRI Study

Journal of Inherited Metabolic Disease, Volume 48, Issue 6, November 2025.
ABSTRACT Classic galactosemia is a rare metabolic disorder resulting from galactose‐1‐phosphate uridylyltransferase deficiency, which disrupts normal galactose metabolism, leading to toxic accumulation of galactose‐1‐phosphate and galactitol. Despite early dietary intervention, patients remain at risk for long‐term neurological impairments, including ...
Eva Niess, Fabian Niess, Wolfgang Bogner, Alena Svatkova, Marion Herle, Lisa Laußner, Lukas Hingerl, Bernhard Strasser, Maximilian Pichler, Vassiliki Konstantopoulou, Miriam Hufgard‐Leitner, Dominic Buchinger, Ivan Milenkovic, Alexandra Kautzky‐Willer, Thomas Stulnig, Thomas Scherer   +15 more
wiley   +1 more source

The stimulation and inhibition of beta-2 adrenergic receptor on the inflammatory responses of ovary and immune system in the aged laying hens

BMC Veterinary Research, 2021
Background Ovarian chronic inflammation has been known to incidence in the laying hen mainly via increasing laying frequency and microbial infection, especially during late stage of production period.
Ali Hatefi, Ahmad Zare Shahneh, Zarbakht Ansari Pirsaraie, Ali Mohammad Alizadeh, Mohammad Pouya Atashnak, Reza Masoudi, Frederic Pio   +6 more
doaj   +1 more source

Taiwan consensus on pulmonary chronic graft‐versus‐host disease: A joint statement from the Taiwan Society of Blood and Marrow Transplantation (TBMT) and Taiwan Society of Pulmonary and Critical Care Medicine (TSPCCM)

British Journal of Haematology, Volume 207, Issue 5, Page 1815-1831, November 2025.
Summary Pulmonary chronic graft‐versus‐host disease (cGVHD), particularly bronchiolitis obliterans syndrome (BOS), is a severe complication of allogeneic haematopoietic stem cell transplantation (allo‐HSCT) with significant morbidity and mortality.
Xavier Cheng‐Hong Tsai, Zong‐Han Yao, Shu‐Wei Chou, Han‐Chung Hu, Yi‐Chang Liu, Chia‐Hung Chen, Su‐Peng Yeh, Wei‐Chang Huang, Tung‐Liang Lin, Tsung‐Ming Yang, Ching‐Han Lai, Hsin‐Kuo Ko, Yao‐Wen Kuo, Hsao‐Hsun Hsu, Shih‐Lung Cheng, Chi‐Cheng Li, Bor‐Sheng Ko, Hao‐Chien Wang, on behalf of the Taiwan Society of Blood and Marrow Transplantation and Taiwan Society of Pulmonary and Critical Care Medicine   +18 more
wiley   +1 more source

Development of Novel Fluticasone/Salmeterol/Tiotropium-Loaded Dry Powder Inhaler and Bioequivalence Assessment to Commercial Products in Rats

Pharmaceutics
Background/Objectives: Inhaler devices have been developed for the effective delivery of inhaled medications used in the treatment of pulmonary diseases.
Hyukjun Cho, Hyunji Lee, Duhyeong Hwang
doaj   +1 more source